What Researchers Did
The researchers followed 48 adults with severe late side effects from radiation treatment who received daily sessions in a hyperbaric chamber at 1.45 ATA and asked them to rate their quality of life before, at the end of, and after treatment.
What They Found
This prospective pilot study of patients with grade 3 late radiation toxicity reported that median quality-of-life scores on the EORTC-QLQ-C30 questionnaire improved in all domains except cognitive function after hyperbaric oxygen therapy (HBOT) at 1.45 ATA, with a mean follow-up of 22.10 months (range 6 to 39). Treatment was 60 minutes daily at 100% oxygen, with 40 sessions prescribed over 8 weeks. Of the 48 patients enrolled, 37 (77%) completed the prescribed sessions, and 30 of those 37 completed follow-up questionnaires. The most common symptoms were pain (65%) and bleeding (54%), and anal fibrosis (9 of 37) and brain necrosis (7 of 37) were the most frequently treated conditions. The cognitive domain did not improve (p = 0.106).
What This Means for Canadian Patients
For people living with severe late radiation injury, this study reports that HBOT at 1.45 ATA was feasible and well tolerated, and that patients rated their physical function, daily activities and general health better over time. The study had no comparison group, so it cannot show that the treatment caused these changes. Anyone considering HBOT after radiotherapy should talk with their cancer care team about whether it fits their situation.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small pilot study with no control group, about a quarter of the enrolled patients did not complete the prescribed treatment, and the results rely on patients' own questionnaire reports, so the findings cannot confirm that HBOT caused the improvements.